Boston Scientific Inc. (BSX): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific ( BSX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.9%. By the end of trading, Boston Scientific rose $0.64 (5.9%) to $11.57 on heavy volume. Throughout the day, 39,189,208 shares of Boston Scientific exchanged hands as compared to its average daily volume of 15,427,400 shares. The stock ranged in a price between $10.95-$11.67 after having opened the day at $10.95 as compared to the previous trading day's close of $10.93. Other companies within the Health Care sector that increased today were: GW Pharmaceuticals PLC ADR ( GWPH), up 89.3%, Rockwell Medical ( RMTI), up 32.5%, MiMedx Group ( MDXG), up 19.8% and Echo Therapeutics ( ECTE), up 12.9%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $14.6 billion and is part of the health services industry. Shares are up 90.8% year to date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance, expanding profit margins, impressive record of earnings per share growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Agenus ( AGEN), down 23.4%, Genvec ( GNVC), down 10.4%, Vivus ( VVUS), down 8.9% and China Pharma ( CPHI), down 8.5% , were all laggards within the health care sector with Novo Nordisk A/S ( NVO) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec

Dow Trades Above 25,000 as U.S.-China Trade Tensions Thaw

Dow Trades Above 25,000 as U.S.-China Trade Tensions Thaw

Treasury Secretary Mnuchin: 'Take the Over' on U.S. GDP Topping 3% This Year

Treasury Secretary Mnuchin: 'Take the Over' on U.S. GDP Topping 3% This Year

Video: Why the Stock Market Is Discounting China Trade Fears for Now

Video: Why the Stock Market Is Discounting China Trade Fears for Now

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000